Takeda Pharmaceutical
Wei Yin possesses extensive experience in clinical pharmacology within the biopharmaceutical sector, having held senior leadership roles at notable companies such as Takeda Pharmaceuticals and Biogen. As Senior Director of Quantitative Clinical Pharmacology at Takeda, Wei guided regulatory interactions and contributed to advanced pharmacological strategies. Prior positions include Clinical Pharmacology lead at Biogen, Vertex Pharmaceuticals, and AVEO Pharmaceuticals, where Wei focused on bioanalysis, cancer research, and clinical research expertise. Wei's academic foundation includes a PhD in Pharmacokinetics and Pharmaceutics from The University of Texas at Austin, complemented by a Bachelor of Science in Pharmacy from Beijing Medical University.
This person is not in any teams
This person is not in any offices
Takeda Pharmaceutical
177 followers
For more than 230 years, Takeda has brought hope to people around the world through its people-centered and innovation-driven approach to science and medicine. As a global pharmaceutical leader, Takeda focuses on solving unmet needs where it can make a real difference—and on putting patients first. Its therapeutics focus is oncology, gastroenterology, and the central nervous system, as well as vaccines.